These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12355506)

  • 1. Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al.
    Maeno N; Takei S; Nomura Y; Imanaka H; Hokonohara M; Miyata K
    Arthritis Rheum; 2002 Sep; 46(9):2539-41; author reply 2541-2. PubMed ID: 12355506
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure to distinguish systemic-onset juvenile idiopathic arthritis from incomplete Kawasaki disease in an infant.
    Komatsu H; Tateno A
    J Paediatr Child Health; 2007 Oct; 43(10):707-9. PubMed ID: 17854457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on failure to distinguish systemic-onset juvenile idiopathic arthritis from incomplete Kawasaki disease in an infant.
    Shin JI; Choi JY; Kim DS
    J Paediatr Child Health; 2008 Nov; 44(11):677-8; author reply 678. PubMed ID: 19012646
    [No Abstract]   [Full Text] [Related]  

  • 4. Interleukin 18 as a marker of disease activity and severity in patients with juvenile idiopathic arthritis.
    Lotito AP; Campa A; Silva CA; Kiss MH; Mello SB
    J Rheumatol; 2007 Apr; 34(4):823-30. PubMed ID: 17343316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum IL-18 as a potential specific marker for differentiating systemic juvenile idiopathic arthritis from incomplete Kawasaki disease.
    Takahara T; Shimizu M; Nakagishi Y; Kinjo N; Yachie A
    Rheumatol Int; 2015 Jan; 35(1):81-4. PubMed ID: 24917023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12.
    Wittkowski H; Hirono K; Ichida F; Vogl T; Ye F; Yanlin X; Saito K; Uese K; Miyawaki T; Viemann D; Roth J; Foell D
    Arthritis Rheum; 2007 Dec; 56(12):4174-81. PubMed ID: 18050248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles.
    Shimizu M; Nakagishi Y; Yachie A
    Cytokine; 2013 Feb; 61(2):345-8. PubMed ID: 23276493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of incomplete Kawasaki disease with extremely high serum ferritin and interleukin-18 levels.
    Noto T; Seto H; Fukuhara J; Murabayashi M; Yachie A; Ayusawa M; Morioka I
    BMC Pediatr; 2018 Dec; 18(1):386. PubMed ID: 30541507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis.
    de Jager W; Vastert SJ; Beekman JM; Wulffraat NM; Kuis W; Coffer PJ; Prakken BJ
    Arthritis Rheum; 2009 Sep; 60(9):2782-93. PubMed ID: 19714583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis?
    Ramanan AV; Grom AA
    Rheumatology (Oxford); 2005 Nov; 44(11):1350-3. PubMed ID: 15956091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The imbalance of IL-18/IL-18BP in patients with systemic juvenile idiopathic arthritis.
    Chen O; Shan N; Zhu X; Wang Y; Ren P; Wei D; Sun R
    Acta Biochim Biophys Sin (Shanghai); 2013 Apr; 45(4):339-41. PubMed ID: 23419721
    [No Abstract]   [Full Text] [Related]  

  • 12. Macrophage activation is a key component in the pathogenesis of systemic juvenile idiopathic arthritis: comment on the article by Blessing et al.
    Bloom BJ
    Arthritis Rheum; 2007 Nov; 56(11):3877-8. PubMed ID: 17968934
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased interleukin-18 expression in bone marrow of a patient with systemic juvenile idiopathic arthritis and unrecognized macrophage-activation syndrome.
    Maeno N; Takei S; Imanaka H; Yamamoto K; Kuriwaki K; Kawano Y; Oda H
    Arthritis Rheum; 2004 Jun; 50(6):1935-8. PubMed ID: 15188370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood.
    Avcin T; Tse SM; Schneider R; Ngan B; Silverman ED
    J Pediatr; 2006 May; 148(5):683-6. PubMed ID: 16737887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is juvenile psoriatic arthritis? Comment on the article by Stoll et al.
    Martini A
    Arthritis Rheum; 2007 Apr; 56(4):1368. PubMed ID: 17393443
    [No Abstract]   [Full Text] [Related]  

  • 16. Soluble intercellular adhesion molecule-1 and E-selectin as markers of disease activity and endothelial activation in juvenile idiopathic arthritis.
    Bloom BJ; Nelson SM; Eisenberg D; Alario AJ
    J Rheumatol; 2005 Feb; 32(2):366-72. PubMed ID: 15693101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anakinra for systemic juvenile arthritis: the Rocky Mountain experience.
    Zeft A; Hollister R; LaFleur B; Sampath P; Soep J; McNally B; Kunkel G; Schlesinger M; Bohnsack J
    J Clin Rheumatol; 2009 Jun; 15(4):161-4. PubMed ID: 19363453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytokine levels in serum of patients with juvenile idiopathic arthritis depending on subtype and disease activity].
    Pietrewicz E; Urban M; Górska A
    Pol Merkur Lekarski; 2004 Sep; 17(99):232-4. PubMed ID: 15628047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis.
    Frosch M; Ahlmann M; Vogl T; Wittkowski H; Wulffraat N; Foell D; Roth J
    Arthritis Rheum; 2009 Mar; 60(3):883-91. PubMed ID: 19248102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
    Bleesing J; Prada A; Siegel DM; Villanueva J; Olson J; Ilowite NT; Brunner HI; Griffin T; Graham TB; Sherry DD; Passo MH; Ramanan AV; Filipovich A; Grom AA
    Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.